Literature DB >> 27004479

COPD control: Can a consensus be found?

M Guimarães1, A Bugalho2, A S Oliveira3, J Moita4, A Marques5.   

Abstract

There are currently no reliable instruments for assessing the onset and progression of chronic obstructive pulmonary disease (COPD) or predicting its prognosis. Currently, a comprehensive assessment of COPD including several objective and subjective parameters is recommended. However, the lack of biomarkers precludes a correct assessment of COPD severity, which consequently hampers adequate therapeutic approaches and COPD control. In the absence of a definition of "well-controlled disease", a consensus regarding COPD control will be difficult to reach. However, COPD patient assessment should be multidimensional, and anchored in five points: control of symptoms, decline of pulmonary function, levels of physical activity, exacerbations, and Quality of Life. Several non-pharmacological and pharmacological measures are currently available to achieve disease control. Smoking cessation, vaccination, exercise training programs and pulmonary rehabilitation are recognized as important non-pharmacological measures but bronchodilators are the pivotal therapy in the control of COPD. This paper discusses several objective and subjective parameters that may bridge the gap between disease assessment and disease control. The authors conclude that, at present, it is not possible to reach a consensus regarding COPD control, essentially due to the lack of objective instruments to measure it. Some recommendations are set forth, but true COPD control awaits further objective assessments.
Copyright © 2016. Published by Elsevier España, S.L.U.

Entities:  

Keywords:  COPD; COPD assessment; Control; Spirometry; Symptoms control; Treatment

Mesh:

Year:  2016        PMID: 27004479     DOI: 10.1016/j.rppnen.2016.01.004

Source DB:  PubMed          Journal:  Rev Port Pneumol (2006)        ISSN: 0873-2159


  2 in total

1.  Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients.

Authors:  Konstantinos Kostikas; Alexander J Mackay; Claus F Vogelmeier; Stefan-Marian Frent; Pritam Gupta; Donald Banerji; Francesco Patalano; Pascal J Pfister; Jadwiga A Wedzicha
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-28

2.  Clinical Control Criteria to Determine Disease Control in Patients with Severe COPD: The CLAVE Study.

Authors:  Juan José Soler-Cataluña; Pere Almagro; Arturo Huerta; Diego González-Segura; Borja G Cosío
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.